Use of atypical antipsychotics in mood disorders

Current Opinion in Investigational Drugs

Volumn 2, Issue 7, 2001, Pages 940-945

  Weizman, R ^a   Weizman, A ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Atypical antipsychotics; Bipolar disorder; Clozapine; Depression; Mood disorders; Olanzapine; Quetiapine; Risperidone; Schizoaffective disorder; Schizophrenia; Ziprasidone

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BIPERIDEN; CLOZAPINE; FLUOXETINE; HALOPERIDOL; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; VALPROATE SEMISODIUM; ZIPRASIDONE;

ACUTE DISEASE; ADD ON THERAPY; AFFECTIVE NEUROSIS; AGRANULOCYTOSIS; BODY WEIGHT DISORDER; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; FOLLOW UP; HUMAN; MAINTENANCE THERAPY; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MONOTHERAPY; PROPHYLAXIS; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHOOL CHILD; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SOMNOLENCE; SYMPTOM; TREATMENT OUTCOME; TREMOR; XEROSTOMIA;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; CLINICAL TRIALS; CLOZAPINE; DEPRESSIVE DISORDER, MAJOR; DIBENZOTHIAZEPINES; HUMANS; PIPERAZINES; PIRENZEPINE; RISPERIDONE; THIAZOLES;

EID: 0034925831     PISSN: 09678298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. The new atypical antipsychotics: A lack of extrapyramidal side-effects and new routes in schizophrenia research
2. Mechanisms of action of atypical antipsychotic drugs: A critical analysis
3. 2 pKi values
4. The role of serotonin in antipsychotic drug action
5. Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia
6. 2 receptor explain the action of atypical antipsychotics? A new hypothesis
7. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine
8. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia
9. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: A meta-analysis of randomized controlled trials
10. Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: A 4-week placebo-controlled trial
11. Prolactin and antipsychotic medications: Mechanism of action
12. Atypical antipsychotics in the treatment of schizophrenia: Systematic overview and meta-regression analysis
13. The pharmacological treatment of delusional depression
14. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression
15. Psychotic (delusional) depression: A meta-analysis of physical treatments
16. Schizoaffective disorder: Role of atypical antipsychotics
17. Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia
18. Clozapine therapy in refractory affective disorders: Polarity predicts response in long-term follow-up
19. Risperidone in the treatment of affective illness and obsessive-compulsive disorder
20. Atypical antipsychotics for treatment of mixed depression and anxiety
21. Management of psychotic, treatment-resistant depression
22. Relapse in delusional depression: A retrospective study of the course of treatment
23. Recurrent psychotic unipolar depression
24. Acute and long term effectiveness of clozapine in treatment resistant psychotic depression
25. Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome
26. Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome - A functional approach
27. Risperidone augmentation of selective serotonin reuptake inhibitors in major depression
28. Olanzapine response in psychotic depression
29. Naturalistic study of olanzapine in treatment-resistant schizophrenia and acute mania, depression and obsessional disorder
30. Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia
31. Adjunctive use of olanzapine in mood disorders: Five case reports
32. A novel augmentation strategy for treating resistant major depression
33. Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex
34. New insights into the biology of schizophrenia through the mechanism of action of clozapine
35. Clozapine in bipolar disorder: Treatment implications for other atypical antipsychotics
36. Clozapine for treatment-refractory mania
37. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania
38. Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: A report of three cases
39. Clozapine in rapid cycling bipolar disorder
40. Long-term risperidone treatment in bipolar disorder: 6-month follow up
41. Acute treatment of bipolar disorder with adjunctive risperidone in outpatients
42. Risperidone treatment for juvenile bipolar disorder: A retrospective chart review
43. Risperidone in the treatment of mania
44. Risperidone treatment of bipolar disorder
45. Treatment of refractory rapid cycling bipolar disorder with risperidone
46. Risperidone compared with both lithium and haloperidol in mania: A double-blind randomized controlled trial
47. Possible induction of mania and hypomania by olanzapine or risperidone: A critical review of reported cases
48. New treatments for bipolar disorder: The role of atypical neuroleptic agents
49. Clinical predictors of acute response with olanzapine in psychotic mood disorders
50. Olanzapine in treatment-resistant bipolar disorder
51. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group
52. Efficacy of olanzapine in acute bipolar mania: A double-blind, placebo-controlled study. The Olanzapine HGGW Study Group
53. Olanzapine compared to lithium in mania: A double-blind randomized controlled trial
54. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder
55. The use of quetiapine for treatment-resistant bipolar disorder: A case series
56. Clinical predictors of acute response with quetiapine in psychotic mood disorders
57. Pharmacologic agents for the treatment of acute bipolar mania
58. Onset of action of antipsychotics in the treatment of mania
59. Antipsychotic drug side effect issues in bipolar manic patients